113 related articles for article (PubMed ID: 38253280)
1. Transcriptional mechanism of E2F1/TFAP2C/NRF1 in regulating KANK2 gene in nephrotic syndrome.
Mao Y; Zhou Y; Chen Y; Xu R; Wu YQ; Zhu WW; Wang XF; Wang Q; Juan CX
Exp Cell Res; 2024 Feb; 435(2):113931. PubMed ID: 38253280
[TBL] [Abstract][Full Text] [Related]
2. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation.
Wang D; Wan B; Zhang X; Sun P; Lu S; Liu C; Zhu L
BMC Gastroenterol; 2022 Apr; 22(1):198. PubMed ID: 35448958
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
5. Nephrotic-syndrome-associated mutation of KANK2 induces pathologic binding competition with physiological interactor KIF21A.
Xu Y; Guo C; Pan W; Zhao C; Ding Y; Xie X; Wei Z; Sun Y; Yu C
J Biol Chem; 2021 Aug; 297(2):100958. PubMed ID: 34274317
[TBL] [Abstract][Full Text] [Related]
6. Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits.
Ramachandran B; Yu G; Gulick T
J Biol Chem; 2008 May; 283(18):11935-46. PubMed ID: 18222924
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human RANK ligand gene expression by E2F1.
Hu Y; Sun M; Nadiminty N; Lou W; Pinder E; Gao AC
Biochem Biophys Res Commun; 2008 Jun; 370(3):440-4. PubMed ID: 18381203
[TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
9. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
10. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
11. E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.
Pellicelli M; Picard C; Wang D; Lavigne P; Moreau A
PLoS One; 2016; 11(11):e0165951. PubMed ID: 27802335
[TBL] [Abstract][Full Text] [Related]
12. Direct repression of the human IRF-3 promoter by E2F1.
Xu HG; Ren W; Zou L; Wang Y; Jin R; Zhou GP
Immunogenetics; 2011 Apr; 63(4):189-96. PubMed ID: 21225257
[TBL] [Abstract][Full Text] [Related]
13. The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.
Huang T; González YR; Qu D; Huang E; Safarpour F; Wang E; Joselin A; Im DS; Callaghan SM; Boonying W; Julian L; Dunwoodie SL; Slack RS; Park DS
J Biol Chem; 2019 May; 294(21):8617-8629. PubMed ID: 30967472
[TBL] [Abstract][Full Text] [Related]
14. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of pref-1 by E2F1 in 3T3 L1 cells.
Shen YN; Kim YM; Yun CH; Moon YS; Kim SH
BMB Rep; 2009 Oct; 42(10):691-6. PubMed ID: 19874716
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a primate-specific E2F1 binding motif regulating MCPH1 expression.
Shi L; Su B
FEBS J; 2012 Feb; 279(3):491-503. PubMed ID: 22136275
[TBL] [Abstract][Full Text] [Related]
17. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
[TBL] [Abstract][Full Text] [Related]
18. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
[TBL] [Abstract][Full Text] [Related]
19. Co-regulation of nuclear respiratory factor-1 by NFkappaB and CREB links LPS-induced inflammation to mitochondrial biogenesis.
Suliman HB; Sweeney TE; Withers CM; Piantadosi CA
J Cell Sci; 2010 Aug; 123(Pt 15):2565-75. PubMed ID: 20587593
[TBL] [Abstract][Full Text] [Related]
20. [Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].
Gao XN; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):806-10. PubMed ID: 19176033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
